News
INCHEON, South Korea I August 6, 2025 I Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback